Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia oil and clotrimazole - tea tree

Journal of Family Practice, June, 1994 by David S. Buck, David M. Nidorf, John G. Addino

(31.)Atkinson N. Antibiotics in Australian plants and fungi. Med J Aust 1949; 1:605-10.

(32.)Maruzzella JC, Liguori L. The in vitro antifungal activity of essential oils. J Am Pharm Assoc 1958; 47:250-4.

(33.)Walker M. A successful antifungal regime. Curr Podiatry 1962; 8:16-9.

(34.)Walker M. Clinical investigation of Australian Melaleuca alternifolia oil for a variety of common foot problems. Curr Podiatry 1972; 2:7-15.

(35.) Pena EF. Melaleuca alternifolia oil, uses for trichomonal vaginitis and other vaginal infections. Obstet Gynecol 1962; 19:793-5.

(36.)Bassett IB, Pannowitz DL, Barnetson RC. A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 1990; 153:455-8.

(37.)Pariser DM. Superficial fungal infections. Postgrad Med 1990; 87:205-14.

(38.)Taplin D, Zaias N, Rebell G, Blank H. Isolation and recognition of dermatophytes on a new medium (DTM). Arch Dermatol 1969; 96:203-9.

(39.)Pariser D, Caserio R, Eaglstein W. Techniques for diagnosing skin and hair disease. 2nd ed. New York: Thieme Inc, 1986:31-9.

(40.)Suarez SM, Silvers DN, Scher RK, et al. Histological evaluation of nail clippings for diagnosing onychomycosis. Arch Dermatol 1991; 127:1517-9.

(41.)Daniel CR III, Lawson L. Tinea unguium. Cutis 1987; 40:326-7.

(42.)Cohen J. Statistical power analysis for the behavioral sciences. New York: Academic Press, 1992.

(43.)Tulli A, Ruffili MP, DeSimone C. The treatment of onychomycosis with a new form of tioconazole. Chemioterapia 1988; 7:160-3.

(44.)Faergemann J, Swanbeck G. Treatment of onychomycosis with a propylene glycol-urea-lactic acid solution. Mycoses 1988; 32: 536-40.

(45.)Wu YC, Chuan MT, Lu YC. Efficacy of ciclopiroxolamine 1% cream in onychomycosis and tinea pedis. Mycoses 1991; 34:93-5.

(46.)Baotian Y, Guangji Z, Baoxi W, et al. A clinical and laboratory study of ciclopiroxolamine (8% batrafen) in the treatment of onychomycosis. Chin Med Sci J 1991; 6:166-8.

(47.)Hay RJ, Roberts DT, Doherty VR, Richardson MD, Midgley G. The topical treatment of onychomycosis using a new combined urea/imidazole preparation. Clin Exp Dermatol 1988; 13:164-7.

(48.)Noltings S. Onychomycoses and their successful therapy. Wien Med Wochenschr 1989; 139:354-5.

(49.)Hardjoko FS, Widyanto S, Singgih I, Susilo J. Treatment of onychomycosis with a bifonazole-urea combination. Mycoses 1990; 33:167-71.

(50.)Klaschka F. Treatment of onychomycosis with naftitine gel. Mycosen 1987; 30(suppl 1):119-23.

(51.)del Palacio A, Lopez-Gomez S, Garcia-Bravo M, et al. Experience with amorolfine in the treatment of dermatomycoses. Dermatology 1992; 184(suppl 1):25-9.

(52.)Daniel CR III. The diagnosis of nail fungal infections. Arch Dermatol 1991; 127:1566-7.

(53.)Forck G. Relationship between the blood circulation of the skin and the development of fungus disease. Zental Bakt Parasitkde 1970; 212:544-53.

(54.)Roberts DT. Current therapy for onychomycosis. J Dermatol Treatment 1990; 1(suppl 2):49-50. Submitted, revised, January 24, 1994.

From the Department of Family Medicine, University of Rochester School of Medicine and Dentistry, Highland Hospital (D.S.B.), and the Department of Podiatric Medicine and Surgery, Strong Memorial Hospital (J.G.A.), Rochester, New York; and Stanislaus Medical Center, University of California at Davis, Davis, California (D.M.N.). Requests for reprints should be addressed to David S. Buck, MD, MPH, La Familia Medical Center, 1121 Alto St, Santa Fe, NM 87502-5395.